REQUEST A DEMO
Total
USD $0.00
Search more companies

Neomedica D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Neomedica D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Neomedica D.O.O. Beograd is an enterprise based in Serbia. Its main office is in Belgrade. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on May 15, 2001. It currently has a total number of 7 (2023) employees. The latest financial highlights indicate a net sales revenue drop of 21.02% in 2023. Its’ total assets recorded a negative growth of 19.87%. The net profit margin of Neomedica D.O.O. Beograd increased by 1.96% in 2023.

Headquarters
Balkanska 2
Belgrade; Belgrade; Postal Code: www.neomedica-bg.com

Contact Details: Purchase the Neomedica D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Neomedica D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Neomedica D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Neomedica D.O.O. Beograd report to view the information.
Incorporation Date:
May 15, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neomedica D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-21.02%
Total operating revenue
-21.02%
Operating profit (EBIT)
-11.48%
EBITDA
-10.6%
Net Profit (Loss) for the Period
-15.21%
Total assets
-19.87%
Total equity
-18.46%
Operating Profit Margin (ROS)
3.78%
Net Profit Margin
1.96%
Return on Equity (ROE)
2.54%
Debt to Equity Ratio
4.31%
Quick Ratio
1.21%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?